` GMAB (Genmab A/S) vs ASND (Ascendis Pharma A/S) Comparison - Alpha Spread

GMAB
vs
ASND

Over the past 12 months, GMAB has underperformed ASND, delivering a return of -20% compared to the ASND's +27% growth.

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
GMAB
ASND
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Valuation
Growth
Profitability
Solvency
Comparing Valuation
Running a multi-layered valuation analysis to compare how attractive each stock is.
Comparing Growth
Financial growth, forecasts, volatility, and historical drawdowns.
Comparing Profitability
Margins, returns on capital, and the consistency of profitability.
Comparing Solvency
Debt levels, liquidity, interest coverage, and bankruptcy risk.
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

GMAB Intrinsic Value
37.46 USD
Undervaluation 45%
Intrinsic Value
Price
ASND Intrinsic Value
209.83 USD
Undervaluation 18%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Genmab A/S
NASDAQ:GMAB
20.44 USD
Ascendis Pharma A/S
NASDAQ:ASND
173.1 USD
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
GMAB vs ASND

GMAB
ASND
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Genmab A/S
Revenue
Ascendis Pharma A/S
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
GMAB vs ASND

GMAB
ASND
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Genmab A/S
NASDAQ:GMAB
Ascendis Pharma A/S
NASDAQ:ASND
What is Free Cash Flow?

Gross Margin

GMAB
95.9%
ASND
85.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Genmab A/S
Ascendis Pharma A/S

Operating Margin

GMAB
31.2%
ASND
-88.5%
LTM 3Y Avg 5Y Avg 10Y Avg
Genmab A/S
Ascendis Pharma A/S

Net Margin

GMAB
30%
ASND
-92.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Genmab A/S
Ascendis Pharma A/S

FCF Margin

GMAB
-1.3%
ASND
-59.9%
LTM 3Y Avg 5Y Avg 10Y Avg
Genmab A/S
Ascendis Pharma A/S

ROE

GMAB
12.6%
ASND
159.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Genmab A/S
Ascendis Pharma A/S

ROA

GMAB
11%
ASND
-36.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Genmab A/S
Ascendis Pharma A/S

ROIC

GMAB
35.4%
ASND
-77.8%
LTM 3Y Avg 5Y Avg 10Y Avg
Genmab A/S
Ascendis Pharma A/S

ROCE

GMAB
12.4%
ASND
-363.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Genmab A/S
Ascendis Pharma A/S

Solvency Comparison

Balance Sheet Comparison

Stocks Performance

Stocks Performance
GMAB vs ASND

Loading

Performance Gap
GMAB vs ASND

Loading
GMAB
ASND
Difference
www.alphaspread.com

Performance By Year
GMAB vs ASND

Loading
GMAB
ASND
Add Stock
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare GMAB to other stocks
Unlock Full Access to Alpha Spread
Create Free Account